Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis
<p>Abstract</p> <p>Objectives</p> <p>Treatment of multiple sclerosis patients with glatiramer acetate has been demonstrated a beneficial effect on disease activity. The objective of this prospective naturalistic study was to evaluate the impact of glatiramer acetate on...
Main Authors: | Apfel Rainer, Hoffman Josef, Ziemssen Tjalf, Kern Simone |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-09-01
|
Series: | Health and Quality of Life Outcomes |
Online Access: | http://www.hqlo.com/content/6/1/67 |
Similar Items
-
Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-03-01) -
Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-03-01) -
Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
by: Aaron Boster, et al.
Published: (2011-09-01) -
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
by: Anne Waschbisch, et al.
Published: (2011-01-01) -
New features of glatiramer acetate for the treatment of remitting multiple sclerosis
by: N. Y. Lasch
Published: (2015-12-01)